Nova Eye Medical Limited (EYE) Q3 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nova Eye Medical Ltd.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.955 Good morning everyone and once again thanks for joining us. 00:00:02.955 -- 00:00:05.198 We'll cover a couple of things today with an over-eye. 00:00:05.198 -- 00:00:09.344 Obviously the March quarter result. We'll cover the record April sales release that we've 00:00:09.344 -- 00:00:12.227 put out to the ASX and our guidance today as well. 00:00:12.227 -- 00:00:15.552 And also we'll give you an update on how the US business is scaling up at this present 00:00:15.552 -- 00:00:20.098 time. Quick reminder, this session may include some forward-looking statements, so please 00:00:20.098 -- 00:00:24.466 refer to the ASX release and the investor presentation for full details. 00:00:24.466 -- 00:00:28.633 As always, if you'd like to ask a question, please use the Q&A function in Zoom and we 00:00:28.633 -- 00:00:33.019 will try and get to as many as we can. I have received a number of questions ahead of 00:00:33.019 -- 00:00:35.844 the meeting, so thank you to those that have sent those through. 00:00:35.844 -- 00:00:40.087 But with no further ado, hands straight over to 00:00:40.411 -- 00:00:44.658 Tom. Thanks, Mark. Thank you very much, everybody, for tuning in today. 00:00:44.658 -- 00:00:49.485 I'm always very pleased with the number of people that take the time to listen to our 00:00:49.485 -- 00:00:54.770 stories. I think we've got a good story again for the quarter to 31 00:00:54.770 -- 00:01:00.398 March 2026. Just a reminder, 00:01:00.398 -- 00:01:04.724 it's about pressure. Glaucoma is about pressure. 00:01:04.724 -- 00:01:10.329 And us intervening in the disease to open 00:01:10.733 -- 00:01:16.141 up blockages and reduce that pressure. Next slide. 00:01:16.141 -- 00:01:17.883 The messages 00:01:17.883 -- 00:01:20.103 from tod...